Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:04 PM
Ignite Modification Date:
2025-12-24 @ 2:04 PM
NCT ID:
NCT03512795
Eligibility Criteria:
Inclusion Criteria:
* Patient who has given consent
* Adult patient
* Patient living with HIV-1
* Controlled viral load (\<50 RNA copies/ml) for at least 1 year.
* At least two previous virologic failures, either :
* Initial failure : defined as the persistence of a viral load greater than 50 copies/ml beyond 1 year, after the initiation of triple antiretroviral therapy, and without virological control (VL \> 50 copies/ml) since the initiation of the very first antiretroviral treatment.
* A rebound in HIV viral load to more than 50 copies/ml after a period of virological success, confirmed on two consecutive samples at least one month apart.
* At least 2 Sanger RNA genotypes have been done or could be done from the existing library.
Exclusion Criteria:
* Patient not affiliated to a medical insurance scheme
* Protected adult
* Pregnant, parturient or breastfeeding woman
* Discontinuation of clinical and immuno-virological follow-up for more than 2 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03512795
Study Brief:
Protocol Section:
NCT03512795